Sign in
CompletedNo phase

Stanford PIPRA Validation Study in an Elderly Orthopedic Population

Key facts

Who runs it
Stanford University
Where
Palo Alto, United StatesSee the site
Trial code
Status
Completed
People taking part
250 people enrolled
Started
30 Apr 2024
Ended
30 Jun 2024
Type of study
Observational
Record updated
22 August 2024

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Surgical patients
  • Greater than or equal to 65 years old
  • ASA I, II or III
  • Greater than 90 min of surgery
  • Non-cardiac surgery

Who cannot take part

  • Previous surgery within the last 12 months or expected in the 12 months to come (except the expected surgery for which they are being enrolled)
  • Dementia
  • Alzheimer's
  • Parkinson's
  • Current Benzodiazepine use
  • Alcoholism
  • Color-blindness

Where in United States

  • Stanford Medical CenterPalo Alto, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine the accuracy of an AI-based tool in the prediction of postoperative delirium (POD), in a population at moderately high risk of developing this syndrome (i.e., elderly orthopedic subjects). The population to be studied has already been enrolled in a parallel study regarding the likelihood of developing delirium, its relationship to the type of anesthetic, and the relationship between anesthetic type, development of delirium and risk for post-operative cognitive impairment (including risk for dementia) (Protocol ID#55169 [David Drover-Principal investigator; José Maldonado-Co-investigator]).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Stanford Study of the Validation of the Pre-Interventional Preventive Risk Assessment (PIPRA) Tool In The At-Risk Orthopedic Surgery Population
Record updated
22 August 2024